| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 97 |
| 1 | OCTREOTIDE ACETATE | 83 |
| 2 | CAPECITABINE | 51 |
| 3 | CARBOPLATIN | 30 |
| 4 | ETOPOSIDE | 29 |
| 5 | TEMOZOLOMIDE | 24 |
| 6 | LUTETIUM LU 177 DOTATATE | 23 |
| 7 | SUNITINIB MALATE | 21 |
| 8 | SITAGLIPTIN | 20 |
| 9 | FLUOROURACIL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 1 | 0.0043 |
| 1 | LUTETIUM LU 177 DOTATATE | 23 | 0.0040 |
| 2 | METYRAPONE | 3 | 0.0030 |
| 3 | OCTREOTIDE ACETATE | 83 | 0.0027 |
| 4 | EVEROLIMUS | 97 | 0.0020 |
| 5 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 6 | DIAZOXIDE | 1 | 0.0014 |
| 7 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| 8 | TEMOZOLOMIDE | 24 | 0.0011 |
| 9 | PASIREOTIDE | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 99 |
| 1 | mTOR Inhibitor Immunosuppressant [EPC] | 98 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 64 |
| 3 | Platinum-based Drug [EPC] | 43 |
| 4 | Alkylating Drug [EPC] | 31 |
| 5 | Topoisomerase Inhibitor [EPC] | 29 |
| 6 | GLP-1 Receptor Agonist [EPC] | 22 |
| 7 | Opioid Agonist [EPC] | 21 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 19 |
| 9 | Somatostatin Analog [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 1 | Somatostatin Analog [EPC] | 19 | 0.0028 |
| 2 | Calcitonin [EPC] | 2 | 0.0006 |
| 3 | Topoisomerase Inhibitor [EPC] | 29 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 64 | 0.0002 |
| 7 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 8 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 9 | Kinase Inhibitor [EPC] | 99 | 0.0002 |